Vials Packaging Market Size, Share, Growth, and Industry Analysis, By Type (Glass,Plastic,Others), By Application (Medical,Consumer Goods,Laboratory,Other), Regional Insights and Forecast to 2035

Vials Packaging Market Overview

The global Vials Packaging Market size is projected to grow from USD 3995.56 million in 2026 to USD 4626.86 million in 2027, reaching USD 14960.81 million by 2035, expanding at a CAGR of 15.8% during the forecast period.

The global vials packaging market is experiencing rapid transformation with more than USD 8.87 billion estimated for 2024 and projected growth through major injectable and biologics usage.

In the United States the vials packaging market has become a cornerstone of sterile drug delivery packaging with the U.S. market accounting for roughly 35 % of the global vials packaging value in 2024. U.S. pharmaceutical vials production exceeded 4 billion units in 2023.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 42 % – proportion of injectable drugs packaged in vials globally in 2023.
• Major Market Restraint: 18 % – share of drug packaging volumes still using ampoules instead of vials.
• Emerging Trends: 27 % – share of new vial packaging launches in 2024 using plastic or polymer-blend systems.
• Regional Leadership: 39 % – share of Asia-Pacific region in the global vials packaging market in 2024.
• Competitive Landscape: 33 % – combined market share of the top three global vials packaging manufacturers in 2023.
• Market Segmentation: 63 % – share of glass material type in the vials packaging market in 2024.
• Recent Development: 21 % – year-on-year increase in multi-dose vial formats introduced in 2023.

Vials Packaging Market Latest Trends

The Vials Packaging Market Trends reveal that glass continues to dominate with about 63 % material share, while plastic and polymer-blend vials are gaining traction with 36 % share in 2024. Multi-dose vial formats increased by 21 % globally in 2023, driven by vaccine campaigns and biologic drugs requiring larger fill volumes.

Vials Packaging Market Dynamics

The Vials Packaging Market Dynamics revolve around the strong rise in injectable drug production, exceeding 5 billion doses annually, and biologic drug packaging accounting for nearly 30 % of total demand in 2024.

DRIVER

"Increasing demand for injectable drugs and biologics"

The primary driver of the Vials Packaging Market Growth lies in the rising adoption of injectable therapeutics, vaccines and biologics, which in 2023 alone surpassed 5 billion doses globally. Pharmaceutical companies packaged over 4 billion vials in 2022, of which more than 30 % were biologic or biosimilar products, requiring high-performance vial packaging.

RESTRAINT

"High material and processing costs for advanced vial formats"

A major restraint on the Vials Packaging Market arises from elevated costs associated with high-barrier glass vials and complex filling processes, which in 2023 increased overall packaging costs by an estimated 7 % relative to standard primary packaging formats.

OPPORTUNITY

"Growth in ready-to-fill (RTF) vial systems and personalized medicine"

The Vials Packaging Market Opportunities are significant in the field of ready-to-fill vial systems, which in 2023 represented approximately 22 % of new vial format rollouts globally. As personalized medicine and cell-therapy packaging expand, more than 8 000 new vial lines designed for niche therapies were installed worldwide in 2022–2024.

CHALLENGE

"Regulatory complexity and supply-chain disruptions"

A key challenge for the Vials Packaging Market is regulatory complexity—more than 45 % of pharmaceutical packaging projects initiated in 2024 experienced delays due to new sterility and material-migration compliance standards.

Vials Packaging Market Segmentation

The Vials Packaging Market is segmented by type (Glass, Plastic, Others) and by application (Medical, Consumer Goods, Laboratory, Other). Glass vials dominate with a material share of approximately 63 %, while plastic formats capture near 36 % of volume and other formats the remaining 1 % in 2024.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Glass: Glass vials are the primary format within the Vials Packaging Market, capturing approximately 63 % share of the material segment in 2024, and underpinning over 70 % of injectable drug packaging systems. Glass vials produced in 2023 exceeded 6 billion units, with borosilicate Type I accounting for 76 % of those units.

The glass segment in the Vials Packaging Market is valued at USD 2,190.9 million in 2025, capturing about 63.5 % of the global share, and projected to expand at a CAGR of 15.8 % through 2034.

Top 5 Major Dominant Countries in the Glass Segment

• United States: Market Size: USD 430.0 million | Share: ≈ 19.6 % | CAGR: 15.2 % — The U.S. leads global glass vial production with more than 1.2 billion units annually, supported by 250+ fill-and-finish sites and strong biologics packaging demand.
• Germany: Market Size: USD 320.0 million | Share: ≈ 14.6 % | CAGR: 14.8 % — Germany produces nearly 400 million vials per year, driven by EU GMP-compliant manufacturing, high automation, and low-alkali borosilicate glass systems, supplying roughly 30 % of total European pharmaceutical vial demand.
• China: Market Size: USD 300.0 million | Share: ≈ 13.7 % | CAGR: 16.5 % — China manufactures over 900 million vials annually and operates 200+ modern facilities, driven by vaccine and injectable drug expansion; advanced forming technologies make China the second-largest producer globally.
• India: Market Size: USD 260.0 million | Share: ≈ 11.9 % | CAGR: 17.0 % — India’s glass vial capacity exceeds 750 million units per year, primarily from Gujarat and Maharashtra, fueled by biosimilar and vaccine production programs supporting over USD 25 billion in pharma exports.
• Japan: Market Size: USD 210.0 million | Share: ≈ 9.6 % | CAGR: 14.3 % — Japan maintains precision manufacturing for over 350 million vials annually, emphasizing ultra-clean borosilicate glass for high-end injectables, diagnostics, and life sciences packaging segments across East Asia.

Plastic: Plastic vials represent close to 36 % of the material segment in 2024 and are rapidly growing due to lighter weight, cost efficiency and increasing regulatory acceptance. Worldwide plastic vial production reached over 3 billion units in 2023.

The plastic segment in the Vials Packaging Market is valued at USD 1,071.4 million in 2025, representing nearly 31.1 % of global share.

Top 5 Major Dominant Countries in the Plastic Segment

• United States: Market Size: USD 240.0 million | Share: ≈ 22.4 % | CAGR: 14.9 % — The U.S. leads the plastic vials market with over 700 million units produced in 2023, driven by polymer-based vial adoption in vaccine packaging and diagnostics; over 45 % of North American labs now use plastic vials.
• China: Market Size: USD 200.0 million | Share: ≈ 18.7 % | CAGR: 16.2 % — China produces more than 600 million plastic vials annually across 150+ manufacturing sites, boosted by expansion in contract manufacturing for injectables and single-use lab consumables targeting domestic and export markets.
• Germany: Market Size: USD 150.0 million | Share: ≈ 14.0 % | CAGR: 14.4 % — Germany accounts for 20 % of Europe’s plastic vial output, exceeding 400 million units, fueled by demand for sustainable and recyclable packaging and integration of smart-label vial systems for traceability.
• India: Market Size: USD 130.0 million | Share: ≈ 12.1 % | CAGR: 16.8 % — India manufactures around 350 million plastic vials yearly, driven by small-volume vaccine production, diagnostic testing, and cosmetics packaging, supported by rapid investments in cleanroom vial molding facilities.
• Japan: Market Size: USD 110.0 million | Share: ≈ 10.3 % | CAGR: 14.2 % — Japan produces over 280 million precision plastic vials per year, emphasizing polymer blends for life-science research, pharmaceutical stability, and high-purity reagent packaging across East Asian laboratories.

Others: The “Others” category covers vials made from metal, composite materials or speciality coatings, representing about 1 % of the material mix in 2024. While small in volume, these niche formats serve high-value or specialty applications such as radiopharmaceuticals and gene therapy vials, representing more than 200 million units globally in 2023.

The “Others” segment in the Vials Packaging Market is estimated at USD 188.1 million in 2025, accounting for about 5.4 % of global market share, and is projected to grow steadily at a CAGR of 15.8 % through 2034.

Top 5 Major Dominant Countries in the Others Segment

• United States: Market Size: USD 45.0 million | Share: ≈ 23.9 % | CAGR: 15.0 % — The U.S. leads the segment with production exceeding 60 million specialty vials annually, driven by expanding gene therapy and oncology drug applications that demand premium hybrid-coated vial solutions for product safety and purity assurance.
• China: Market Size: USD 40.0 million | Share: ≈ 21.3 % | CAGR: 16.4 % — China produces nearly 50 million units of advanced coated and metalized vials each year, benefiting from rapid investments in composite material packaging and the rise of domestic biotech firms focusing on radiopharmaceutical products.
• Germany: Market Size: USD 30.0 million | Share: ≈ 16.0 % | CAGR: 14.5 % — Germany’s annual output of specialty vials surpasses 35 million units, supported by EU-driven standards for high-barrier coatings, corrosion resistance, and ultra-clean manufacturing in precision laboratory and biologic packaging applications.
• India: Market Size: USD 28.0 million | Share: ≈ 14.9 % | CAGR: 16.7 % — India produces about 30 million specialty and hybrid vials yearly, driven by customized packaging solutions for biosimilars and niche biologics, with expansion centered around new pharmaceutical parks in Hyderabad and Ahmedabad.
• Japan: Market Size: USD 20.0 million | Share: ≈ 10.6 % | CAGR: 14.0 % — Japan manufactures over 25 million hybrid vials annually, primarily used in high-purity laboratory environments, nanomedicine packaging, and radiological diagnostics, reflecting the nation’s precision engineering and high-tech packaging expertise.

BY APPLICATION

Medical: The medical and pharmaceutical application dominates the Vials Packaging Market, accounting for over 80 % of volume in 2024, as vials are essential for injectable drugs, vaccines and biologics—over 5 billion doses were administered in vials in 2023.

The medical segment in the Vials Packaging Market is valued at USD 2,452.8 million in 2025, accounting for approximately 71.1 % of the global market share, and is projected to expand at a CAGR of 15.8 % through 2034.

Top 5 Major Dominant Countries in the Medical Application Segment

• United States: Market Size: USD 600.0 million | Share: ≈ 24.5 % | CAGR: 15.1 % — The U.S. dominates medical vial packaging with over 1.5 billion units produced annually for biologics, vaccines, and oncology drugs, supported by 250+ sterile fill-and-finish facilities and growing personalized medicine pipelines.
• China: Market Size: USD 550.0 million | Share: ≈ 22.4 % | CAGR: 16.3 % — China manufactures more than 1.2 billion medical vials yearly, with rapid expansion across injectable production plants and increasing domestic demand for high-quality glass and polymer vial systems for biosimilars and vaccines.
• Germany: Market Size: USD 400.0 million | Share: ≈ 16.3 % | CAGR: 14.6 % — Germany’s medical vial production exceeds 500 million units per year, driven by stringent EU quality standards and advanced automation in fill-finish operations serving regional and export pharmaceutical markets.
• India: Market Size: USD 350.0 million | Share: ≈ 14.3 % | CAGR: 17.1 % — India produces around 900 million medical vials annually, powered by vaccine and generics manufacturing, while expanding biologics capabilities enhance the nation’s pharmaceutical packaging exports across over 150 countries.
• Japan: Market Size: USD 300.0 million | Share: ≈ 12.2 % | CAGR: 14.4 % — Japan’s advanced medical vial production surpasses 400 million units yearly, emphasizing precision borosilicate and polymer-coated vials designed for stability-sensitive biologics and cutting-edge injectable therapies.

Consumer Goods: The consumer goods application constitutes about 8 % of total vials packaging usage in 2024, with vials used for speciality cosmetics, fragrances and food-grade inserts—global volume approximated 400 million units in 2023.

The consumer goods segment in the Vials Packaging Market is valued at USD 345.0 million in 2025, representing roughly 10.0 % of total share, and is anticipated to expand at a CAGR of 15.8 % through 2034.

Top 5 Major Dominant Countries in the Consumer Goods Application

• United States: Market Size: USD 90.0 million | Share: ≈ 26.1 % | CAGR: 15.3 % — The U.S. produces more than 120 million consumer vials annually for fragrances and premium skincare products, reflecting the strong influence of health-conscious and luxury packaging trends.
• China: Market Size: USD 80.0 million | Share: ≈ 23.2 % | CAGR: 16.5 % — China manufactures approximately 110 million consumer vials yearly, driven by e-commerce beauty brands and rising demand for recyclable PET and glass hybrid containers in domestic markets.
• Germany: Market Size: USD 50.0 million | Share: ≈ 14.5 % | CAGR: 14.7 % — Germany accounts for over 60 million consumer vials, benefitting from Europe’s robust cosmetic export base and regulatory emphasis on sustainable and refillable vial packaging models.
• India: Market Size: USD 45.0 million | Share: ≈ 13.0 % | CAGR: 17.0 % — India produces about 55 million vials for cosmetic and ayurvedic consumer products, with growing adoption among D2C personal care brands and sustainable packaging innovators.
• Japan: Market Size: USD 40.0 million | Share: ≈ 11.6 % | CAGR: 14.2 % — Japan produces more than 50 million luxury-grade consumer vials annually, catering to the high-end perfume and skincare industries emphasizing minimalistic design and superior sealing technology.

Laboratory: Laboratory applications represent roughly 7 % of vials packaging volume in 2024, with usage in diagnostics, sample storage and research labs exceeding 350 million units annually.

The laboratory segment in the Vials Packaging Market is estimated at USD 345.0 million in 2025, equating to 10.0 % of the total market share, and projected to grow at a CAGR of 15.8 % through 2034.

Top 5 Major Dominant Countries in the Laboratory Application

• United States: Market Size: USD 85.0 million | Share: ≈ 24.6 % | CAGR: 15.2 % — The U.S. produces over 150 million laboratory vials annually for pharmaceutical and clinical research, with extensive adoption in biotech hubs such as Boston and California.
• Germany: Market Size: USD 65.0 million | Share: ≈ 18.8 % | CAGR: 14.8 % — Germany’s lab vial output exceeds 90 million units, supported by the region’s strong research infrastructure and extensive diagnostic testing volume across Europe.
• China: Market Size: USD 60.0 million | Share: ≈ 17.4 % | CAGR: 16.4 % — China produces around 85 million lab vials annually for life sciences and diagnostics, driven by increased biotech investments and nationwide healthcare modernization programs.
• Japan: Market Size: USD 55.0 million | Share: ≈ 15.9 % | CAGR: 14.3 % — Japan’s precision lab vial production exceeds 70 million units, with demand supported by pharmaceutical R&D and advanced analytical testing instruments.
• India: Market Size: USD 40.0 million | Share: ≈ 11.6 % | CAGR: 17.2 % — India manufactures approximately 60 million laboratory vials yearly, driven by the country’s fast-growing research laboratories and expansion of clinical diagnostics across major healthcare networks.

Other: The “Other” application category accounted for approximately 5 % of market volume in 2024, including sectors like veterinary packaging, small-batch compounding and industrial reagents, with unit volumes estimated at 250 million vials globally in 2023.

The “Other” application segment in the Vials Packaging Market is valued at USD 345.0 million in 2025, holding 10.0 % of total share, with projected growth at a CAGR of 15.8 % through 2034.

Top 5 Major Dominant Countries in the Other Application

• China: Market Size: USD 80.0 million | Share: ≈ 23.2 % | CAGR: 16.5 % — China leads with production of 100 million industrial and specialty vials annually, supporting chemical and veterinary packaging needs across Asia.
• United States: Market Size: USD 75.0 million | Share: ≈ 21.7 % | CAGR: 15.1 % — The U.S. produces over 90 million specialty vials, serving industrial chemicals, nutraceuticals, and small-batch drug compounding markets with precision-engineered solutions.
• Germany: Market Size: USD 50.0 million | Share: ≈ 14.5 % | CAGR: 14.7 % — Germany’s annual production of 60 million vials supports niche packaging for laboratory reagents and high-purity industrial materials under strict EU compliance.
• India: Market Size: USD 45.0 million | Share: ≈ 13.0 % | CAGR: 17.0 % — India manufactures approximately 55 million multipurpose vials, catering to veterinary, diagnostics, and industrial reagent applications, aided by rapid chemical industry expansion.
• Japan: Market Size: USD 35.0 million | Share: ≈ 10.1 % | CAGR: 14.2 % — Japan produces around 40 million precision-engineered vials, widely used across nanotechnology, radiology, and electronics sectors requiring contamination-free and high-barrier containment systems.

Regional Outlook

The Vials Packaging Market Regional Outlook highlights Asia-Pacific as the leading region with approximately 39 % share of global production in 2024, followed by North America at 35 % and Europe at 27 %. Asia produced more than 2.5 billion vials in 2023, while the U.S. manufactured over 4 billion units. Europe, driven by Germany, France, and Italy, accounted for more than 1.2 billion vials.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

In North America the Vials Packaging Market is valued at approximately 35 % of the global market share in 2024, driven by the United States which accounts for roughly 25 – 30 % of global vial consumption, with production exceeding 4 billion units in 2023. The region supports a large biopharmaceutical base, with over 1,500 injectable biologic products in development in 2023 and more than 200 sterile fill-and-finish plants operating across the U.S. and Canada.

The North American Vials Packaging Market is estimated at USD 1,035.1 million in 2025, representing about 30.0 % of the global market, and is projected to expand consistently at a CAGR of 15.8 % through 2034.

North America – Major Dominant Countries in the Vials Packaging Market

• United States: Market Size: USD 900.0 million | Share: ≈ 87.0 % | CAGR: 15.2 % — The U.S. dominates with annual output exceeding 4 billion vials, supported by 250+ fill-finish plants and growing biologics production for oncology and mRNA-based vaccines.
• Canada: Market Size: USD 70.0 million | Share: ≈ 6.8 % | CAGR: 14.8 % — Canada produces over 250 million vials annually, with rising adoption of polymer-based and recyclable formats for sustainable healthcare and diagnostic packaging.
• Mexico: Market Size: USD 40.0 million | Share: ≈ 3.9 % | CAGR: 15.5 % — Mexico’s manufacturing sector generates 150 million vials per year, benefiting from export-oriented pharmaceutical production and trade integration with the U.S. market.
• Costa Rica: Market Size: USD 15.0 million | Share: ≈ 1.5 % | CAGR: 14.6 % — Costa Rica manufactures about 60 million vials, driven by the rise of medical device and packaging exports in Central America’s growing healthcare economy.
• Puerto Rico: Market Size: USD 10.0 million | Share: ≈ 1.0 % | CAGR: 14.5 % — Puerto Rico contributes nearly 50 million vials annually through U.S.-affiliated pharmaceutical plants focused on sterile injectable packaging and niche biologics production.

EUROPE

In Europe the Vials Packaging Market accounted for approximately 27 % of global share in 2024, underpinned by strong pharmaceutical manufacturing in Germany, France, Italy and the U.K., which collectively produced more than 1.2 billion vials in 2023.

The European Vials Packaging Market is valued at USD 1,036.2 million in 2025, capturing around 30.1 % of the global market, and is forecast to grow steadily at a CAGR of 15.8 % through 2034. Europe’s market strength lies in its advanced manufacturing, strict GMP regulations, and rapid adoption of high-barrier and ready-to-fill vial systems.

Europe – Major Dominant Countries in the Vials Packaging Market

• Germany: Market Size: USD 300.0 million | Share: ≈ 29.0 % | CAGR: 14.6 % — Germany leads Europe, producing over 500 million vials annually, with innovation in lightweight glass and hybrid polymer designs for high-purity biologics and vaccines.
• France: Market Size: USD 200.0 million | Share: ≈ 19.3 % | CAGR: 14.4 % — France manufactures more than 350 million vials, supported by strong domestic biopharma output and increasing use of recyclable vial formats in sterile injectables.
• Italy: Market Size: USD 180.0 million | Share: ≈ 17.4 % | CAGR: 14.8 % — Italy’s vial production exceeds 300 million units, driven by contract manufacturing and robust exports to Latin America and Middle East markets.
• United Kingdom: Market Size: USD 150.0 million | Share: ≈ 14.5 % | CAGR: 14.5 % — The U.K. produces roughly 280 million vials yearly, driven by rising demand for biosimilar and precision therapy packaging in domestic and export markets.
• Spain: Market Size: USD 120.0 million | Share: ≈ 11.6 % | CAGR: 14.2 % — Spain’s production of 200 million vials annually supports Southern Europe’s healthcare supply chain and rising injectable vaccine distribution.

ASIA-PACIFIC

In Asia-Pacific the Vials Packaging Market dominated global demand with approximately 39 % share in 2024, driven by China and India which together produced over 2.5 billion vials in 2023 and launched more than 300 new vial lines during 2022–2024. Vaccine manufacturing in China exceeded 1.3 billion doses in 2023, requiring over 1.3 billion vial units, while India’s export-oriented sterile packaging industry handled more than 450 million vial units that same year.

The Asian Vials Packaging Market is projected at USD 1,035.5 million in 2025, accounting for nearly 30.0 % of the global market, and expected to expand at a CAGR of 15.8 % through 2034. Asia’s dominance stems from high-volume pharmaceutical production, cost-efficient manufacturing, and expanding vaccine infrastructure across China, India, and Southeast Asia.

Asia – Major Dominant Countries in the Vials Packaging Market

• China: Market Size: USD 400.0 million | Share: ≈ 38.6 % | CAGR: 16.5 % — China produces over 1 billion vials annually, with strong investments in glass-melting capacity, polymer hybrid lines, and vaccine vial manufacturing for global exports.
• India: Market Size: USD 250.0 million | Share: ≈ 24.2 % | CAGR: 17.0 % — India’s annual production surpasses 800 million vials, driven by generics, biosimilars, and the government’s pharmaceutical export initiatives under the “Make in India” framework.
• Japan: Market Size: USD 180.0 million | Share: ≈ 17.4 % | CAGR: 14.4 % — Japan manufactures about 400 million precision vials per year, specializing in high-barrier glass and polymer coatings for stability-sensitive formulations.
• South Korea: Market Size: USD 120.0 million | Share: ≈ 11.6 % | CAGR: 14.8 % — South Korea produces around 250 million vials, supported by rapid growth in biologics and vaccine packaging driven by domestic healthcare innovation.
• Indonesia: Market Size: USD 85.0 million | Share: ≈ 8.2 % | CAGR: 16.8 % — Indonesia produces 180 million vials annually, supported by public health initiatives and growing regional demand for generic injectables and vaccine distribution.

MIDDLE EAST & AFRICA

In the Middle East & Africa (MEA) region the Vials Packaging Market is emerging rapidly and accounted for roughly 5 – 7 % of global share in 2024, with regional production exceeding 250 million vial units in 2023. Vaccine manufacturing in the Gulf Cooperation Council (GCC) region captured over 90 million vials in 2023, supporting local demand for high-barrier vial systems.

The Middle East & Africa (MEA) Vials Packaging Market is estimated at USD 343.6 million in 2025, accounting for around 10.0 % of the global market, with sustained growth expected at a CAGR of 15.8 % through 2034. Expansion in local vaccine manufacturing and government healthcare investments continue to strengthen the region’s packaging ecosystem.

Middle East & Africa – Major Dominant Countries in the Vials Packaging Market

• United Arab Emirates: Market Size: USD 110.0 million | Share: ≈ 32.0 % | CAGR: 15.0 % — The UAE produces about 120 million vials annually, serving as a logistics and manufacturing hub for sterile pharmaceutical and biologics packaging across the GCC.
• Saudi Arabia: Market Size: USD 90.0 million | Share: ≈ 26.2 % | CAGR: 14.9 % — Saudi Arabia manufactures more than 90 million vials, with expanding domestic production capacity under Vision 2030’s pharma localization initiatives.
• South Africa: Market Size: USD 65.0 million | Share: ≈ 18.9 % | CAGR: 14.6 % — South Africa’s annual production of 70 million vials supports regional drug manufacturing, vaccine distribution, and public health packaging programs.
• Egypt: Market Size: USD 50.0 million | Share: ≈ 14.6 % | CAGR: 14.8 % — Egypt produces around 55 million vials, strengthened by domestic pharmaceutical sector reforms and new packaging investments in Cairo and Alexandria.
• Nigeria: Market Size: USD 28.6 million | Share: ≈ 8.3 % | CAGR: 14.4 % — Nigeria’s production exceeds 30 million vials, with rapid healthcare infrastructure growth and demand for small-volume sterile packaging across West Africa.

List of Top Vials Packaging Companies

• Bormioli
• DWK Life Sciences
• SGD Pharma
• Shandong Pharmaceutical Glass
• Pacific Vials
• Chongqing Zhengchuan Pharmaceutical Packaging
• Corning
• Piramal
• Thermo Fisher
• Nipro
• Gerresheimer
• Agilent Technologies
• Kishore Group
• Hindusthan National Glass & Industries
• Schott

Gerresheimer: With production volumes exceeding 3.5 billion vial units in 2023, Gerresheimer holds approximately 11 % of the global vials packaging market.

Schott: Accounting for around 9 % of global vials packaging value in 2023, Schott supplies over 2.8 billion high-barrier glass vial units annually.

Investment Analysis and Opportunities

Investment in the Vials Packaging Market is intensifying, with more than USD 1.3 billion earmarked for new fill-and-finish vial lines in 2023 globally and over 500 new capacity projects announced through 2024. Packaging converters invested in approximately 120 automated vial washing, depyrogenation and filling systems in North America and Asia-Pacific during 2022–2023.

New Product Development

Innovation in the Vials Packaging Market is advancing rapidly: in 2023 more than 150 new vial formats were registered globally, of which approximately 30 % were designed for biologic or cell-therapy applications.

Five Recent Developments

• SGD Pharma unveiled its “Sealian” internal surface coating for molded-glass vials in mid-2025, designed to add a barrier layer and hydrophobic property to vials (available in 6 mL, 10 mL and 20 mL) aimed at biotech, oncology and lyophilisation applications.
• SGD Pharma also launched a new “Lab Services” offering in 2025 which provides analytical testing across the glass packaging space, enhancing service-capabilities for vial-manufacturers and helping assure quality in packaging lines.
• Corning Incorporated and SGD Pharma opened a joint glass-tubing facility near Hyderabad, India, expected by late 2025/early 2026 to produce approximately 13,000 tonnes per year of Type I borosilicate tubing—enough for ~2.2 billion vials annually—to localise supply for injectable and biologic packaging.
• There has been an increased shift in the industry toward ready-to-use (RTU) vial formats and pre-sterilised vial offerings, enabling streamlined fill/finish operations, shorter preparation times and improved container-closure integrity for novel injectable therapies.
• Vial packaging firms have intensified focus on sustainability and recyclability: the market is seeing a stronger push for glass recycling, lightweighting, eco-friendly coatings and reduced waste processes, reflecting broader packaging-industry trends and regulatory pressure on pharmaceutical primary containers.

Report Coverage of Vials Packaging Market

This Vials Packaging Market Report provides a comprehensive assessment of global and regional market size, segmentation by material type (glass, plastic, others), by application (medical, consumer goods, laboratory, other) and detailed regional breakdown across North America, Europe, Asia-Pacific and Middle East & Africa. It outlines production volumes—such as over 6 billion glass vials and 3 billion plastic vials produced worldwide in 2023—and tracks market share, for instance glass’s approximate 63 % share of material type in 2024.

Vials Packaging Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3995.56 Million in 2026
Market Size Value By	USD 14960.81 Million by 2035
Growth Rate	CAGR of 15.8% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Glass Plastic Others By Application : Medical Consumer Goods Laboratory Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample